CAMBRIDGE, Mass., Oct. 3, 2024 /PRNewswire/ -- Invaio Sciences, a
Flagship Pioneering bioplatform company focused on accelerating the
leap to nature-positive agriculture, today announced the
appointment of André Andonian as the new Chairman of its Board of
Directors. Robert Berendes has
decided to step down after serving as Chairman of the Board since
2019 and will continue to serve on the board of Invaio.
Andonian is Chair of Asia
Pacific and Strategic Advisor at Flagship Pioneering, where
he and Ignacio Martinez are
responsible partners for Invaio. He is also Senior Partner
Emeritus at McKinsey & Company, where he has advised companies
in advanced industries for more than 30 years. Andonian's
background in driving strategic transformations across diverse
industries aligns perfectly with Invaio's mission to revolutionize
agriculture by providing farmers with more natural crop
protection.
"We are thrilled to have André take on the role of Chairman. His
deep understanding of global industries, strategic acumen, and
passion for sustainable solutions make him the ideal leader to
guide Invaio into its next phase of growth and innovation," said
Ignacio Martinez, General Partner at
Flagship Pioneering. "I would also like to thank Robert for his
important contribution to Invaio over the last five years and look
forward to our continued collaboration."
In addition to his role at McKinsey, Andonian has also held
influential positions in various industries, including serving on
the boards of leading companies, foundations and educational
institutions.
"I am honored to take on the role of Chairman at Invaio
Sciences," said Andonian. "The company's approach to agriculture,
grounded in cutting-edge science and a deep respect for nature, is
truly transformative. I look forward to working with the team to
accelerate Invaio's impact on sustainable agriculture, ensuring a
healthier and more productive future for farmers and consumers
alike."
As Chairman, Andonian will play a key role in guiding Invaio's
strategic direction, fostering partnerships, and scaling its
innovative solutions to meet the challenges of modern agriculture.
His appointment reflects Invaio's continued dedication to building
a leadership team with the expertise and vision to drive meaningful
change in the global agricultural sector.
About André Andonian
André Andonian is Chair of Asia
Pacific and Strategic Advisor at Flagship Pioneering. He has
over three decades of experience advising companies around the
globe on a broad range of strategic, operational, and
organizational topics, with a longstanding presence in the APAC
region.
Andonian is Senior Partner Emeritus at McKinsey & Company,
where he worked for 34 years, including as Senior Partner, Chairman
of Japan, and Managing Partner of
Korea. He also led Client Impact & Experience across
Asia and was a member of
McKinsey's leadership teams in Asia, Europe,
and the United States, advising
clients in the high-tech, industrial, automotive & assembly,
aerospace, basic materials, biotech, and private equity sectors. He
was a long-term member of the firm's global board and held
extensive additional senior leadership roles in support of growth,
people, and overall knowledge development. Prior to joining
McKinsey, Andonian worked at Masco Corporation in the US and at IBM
in Austria, Spain, and the Middle East.
Andonian also serves as an Independent Director of the Board of
ADI, Chair of the Board of Cognaize in the US, and NC Chair of AEM
Holdings in Singapore. He is a
member of the Advisory Board of the Sports & Health Sciences
Department of the Technical University of Munich, chairs the Foundation for Armenian
Science and Technology, and is a Special Advisor to the American
Chamber of Commerce in Korea.
As a Fulbright Scholar, Andonian received an MBA at the Wharton
School of the University of
Pennsylvania, an MA and BA in Social & Economic Sciences
as well as a BSc in Engineering, all with highest distinction, from
institutions in his hometown of Vienna, Austria.
About Invaio
Invaio Sciences, a Flagship Pioneering
company, is a bioplatform company accelerating the leap to
nature-positive agriculture. The company builds on advances in
human health and digital innovation to develop biological
technologies for crop health, enabling farmers to both improve
yields and use more natural crop health solutions. Invaio is
addressing consumer demands and unlocking radical benefits for
farmers and the environment, leaving every acre better today and
for generations to come. For more information, please
visit www.invaio.com or follow Invaio on X
(Twitter) or LinkedIn.
About Flagship Pioneering
Flagship Pioneering invents
and builds bioplatform companies, each with the potential for
multiple products that transform human health or sustainability.
Since its launch in 2000, Flagship has originated and fostered more
than 100 scientific ventures, resulting in more than $75 billion in aggregate value. To date, Flagship
has deployed over $3.8 billion in
capital toward the founding and growth of its pioneering companies
alongside more than $27 billion of
follow-on investments from other institutions. The current Flagship
ecosystem comprises 40 companies, including Foghorn
Therapeutics (NASDAQ: FHTX), Moderna (NASDAQ: MRNA), Omega
Therapeutics (NASDAQ: OMGA), Sana Biotechnology (NASDAQ:
SANA), Generate Biomedicines, Inari, Indigo Agriculture,
and Tessera Therapeutics.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/invaio-sciences-appoints-andre-andonian-as-chairman-of-the-board-of-directors-302266751.html
SOURCE Invaio Sciences
